02 Grade & presentation

CoQ10 grades: the powder, the oil suspension and the form question

Technical document 02 · Reviewed 2026-11-20 · Coenzyme Q10

On this page
  1. Why one molecule arrives in several presentations
  2. The presentations side by side
  3. Melting point, flow and the process
  4. Assay arithmetic and the dosage form
  5. What to write into the specification
  6. When this grade is the wrong choice

Coenzyme Q10 is supplied as ubiquinone in several physical presentations: a crystalline powder milled to 80 mesh, a granulated powder and an oil suspension. The grade changes particle size, flow and carrier; it does not change the molecule, the CAS number or the assay basis. Ubiquinol is a different product, not a grade of this one.

In one line

The grade of coenzyme Q10 is a presentation decision — particle size, carrier and flow — while the form decision is ubiquinone or ubiquinol, a different product.

Why one molecule arrives in several presentations

Ubiquinone is a lipophilic crystalline solid with a melting range of 48–52 °C. The native powder has a low bulk density, is prone to static and is not especially free-flowing, which matters on a tableting line or in a premix. Milling controls the particle size, but it cannot fix flow on its own; granulation can. A softgel fill needs the material dispersed in oil rather than as a dry powder. A stick pack or a beverage concentrate needs a dispersion that behaves in water, which the native powder does not provide.

Those are presentation decisions, and each one changes the specification in a different place. Granulation moves particle size and bulk density. An oil suspension adds a carrier, a concentration and a carrier specification. A water-dispersible grade adds an emulsifier or a carrier and changes the assay per gram of the finished powder. None of them changes the identity of the ubiquinone.

“Grade” is also used loosely to mean assay. In this catalog the assay range is fixed at 98.0–101.0% by HPLC on the anhydrous basis. A 50% dilution is not a lower grade of the same product; it is a different specification with a carrier, a different assay per gram and a different label declaration.

The presentations side by side

Coenzyme Q10 presentations and what each one changes
PresentationWhat it isWhat changesTypical use
Native powder, 80 meshCrystalline ubiquinone, milledBaseline particle size; dust and static remainCapsules, tablets, dry premix
Granulated powderAgglomerated ubiquinoneFlow, bulk density, dust and dispersionHigh-speed tableting, premix
Oil suspensionUbiquinone dispersed in a vegetable oilCarrier, concentration, viscosity and settlingSoftgel fill, oil-based blend
Water-dispersible powderUbiquinone on a carrier with an emulsifierDispersion in water, assay per gram, labelStick packs, beverage mixes

The catalog supplies the 80 mesh powder as standard and an oil suspension on request. Granulation and water-dispersible forms are separate specifications: they need their own carrier, assay per gram, particle-size method and stability data. A quotation that says only “granulated” has not yet said what the granule is made of.

The table deliberately leaves ubiquinol out. Ubiquinol is the reduced form, with its own CAS number, assay, colour and stability profile. It is compared with ubiquinone on the level-four page, not on a grade list.

Melting point, flow and the process

The melting range of 48–52 °C is not a remote laboratory number. A process that brings the powder surface to 50 °C is at the melting range, not merely warm. Softgel drying, tablet compression and any warming step used to disperse the powder in oil should be reviewed against that range. Melting and re-solidifying can change the crystal form, the bulk density and the flow, even when the assay is unchanged.

Particle size is specified as ≥95% through 80 mesh. That is a ceiling, not a target: a powder can meet it and still flow poorly if the fines dominate. Granulation is the usual answer when flow is the problem. An oil suspension replaces flow with viscosity and settling, so the specification moves to the carrier, the solids load and the resuspension test.

All presentations are light-sensitive. A clear jar on a bench is the wrong container, and a transparent softgel still needs an opaque pack for storage.

Assay arithmetic and the dosage form

The label dose and the weigh-up have to agree. At 99.0% assay on the anhydrous basis and 0.6% loss on drying, the powder as weighed is 98.4% ubiquinone. A label that declares 100 mg of coenzyme Q10 therefore needs 101.6 mg of powder. The arithmetic is not a recommended intake; it is the conversion that keeps the label and the batch record consistent.

An oil suspension adds a second conversion. If the suspension contains 20% ubiquinone by mass, a 100 mg label dose needs 500 mg of suspension. The carrier is not inert for the label: it has to be declared, and its own specification, peroxide value and storage condition belong in the file. A suspension that settles in the drum needs a resuspension step before filling, and that step belongs in the process description.

A water-dispersible powder is specified by the assay of the premix, not by the assay of the ubiquinone inside it. A 20% premix delivers 20 mg of ubiquinone per 100 mg of powder; the label, the weigh-up and the COA all have to use the premix figure.

The dosage form decides which presentation is practical. A hard capsule takes the native or granulated powder. A softgel takes the oil suspension. A stick pack takes a water-dispersible grade or a carefully stabilised emulsion. A tablet takes a granulated powder with a particle size and flow that suit the press.

What to write into the specification

  • “Ubiquinone (coenzyme Q10), CAS 303-98-0, C59H90O4, oxidised form.”
  • “Assay 98.0–101.0% by HPLC on the anhydrous basis; loss on drying ≤1.0%.”
  • “Melting point 48–52 °C; identification by HPLC retention and UV spectrum.”
  • “Particle size ≥95% through 80 mesh; appearance yellow to orange-yellow powder.”
  • “Oil suspension: carrier, ubiquinone concentration, viscosity and resuspension test.”
  • “Granulated or water-dispersible grade: carrier, assay per gram, particle size and dispersion test.”
  • “Light-resistant pack, lot code and a COA for each lot.”

Write the presentation into the product name as well as the specification. “Coenzyme Q10 98%” does not say whether the buyer is receiving a powder, a granule or an oil suspension, and the three do not substitute for one another at the weighing step.

When this grade is the wrong choice

If the label names ubiquinol, ubiquinone is the wrong product, whatever the assay says. If the formula needs a transparent aqueous drink, the native powder will not deliver it; a water-dispersible grade or an emulsion is a separate development project. If the capsule is small and the label dose is large, the low bulk density of the native powder may not fit, and granulation changes the volume without changing the dose.

The reverse is also true. A granulated or water-dispersible grade should not be ordered as a substitute for the native powder without checking the carrier, the assay per gram and the label. The carrier is part of the product, and it brings its own allergen, GMO and stability questions.

Catalog data is on the coenzyme Q10 product page; the comparison with the reduced form is on the ubiquinol product page and the level-four page; the release tests are on the COA page; the pack and lead time are on the MOQ page.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation